Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 1.02MInvested Capital
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Invested Capital Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - Inv. Capital Historical data
| Date | Total Debt | Shareholders Equity | Invested Capital |
|---|---|---|---|
| 6/30/2025 | $ 108.69M | $ -107.67M | $ 1.02M |
| 3/31/2025 | $ 105.53M | $ -90.17M | $ 15.35M |
| 12/31/2024 | $ 102.57M | $ -93.1M | $ 9.47M |
| 9/30/2024 | $ 104.6M | $ -85.63M | $ 18.97M |
| 6/30/2024 | $ 103.26M | $ -74.3M | $ 28.96M |
| 3/31/2024 | $ 101.98M | $ -72.36M | $ 29.62M |
| 12/31/2023 | $ 101.04M | $ -56.51M | $ 44.53M |
| 9/30/2023 | $ 99.62M | $ -40.61M | $ 59.01M |
| 6/30/2023 | $ 97.46M | $ 5.86M | $ 103.33M |
| 3/31/2023 | $ 95.77M | $ 53.01M | $ 148.77M |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) Inv. Capital stands at $ 222.41M.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average Inv. Capital has been $ 131.36M.
- The median Inv. Capital for BIOXCEL THERAPEUTICS INC during this period was $ 159.69M
- BIOXCEL THERAPEUTICS INC reached its highest Inv. Capital over the past 5 years at $ 268.67M.
- The lowest Inv. Capital recorded by BIOXCEL THERAPEUTICS INC in the same timeframe $ 1.02M
BIOXCEL THERAPEUTICS INC's Inv. Capital vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inv. Capital Benchmarks
Similar metrics to Inv. Capital:
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Cash Return on Invested Capital - [Calculation] Cash Return on Invested Capital (CROIC) measures how well a company uses its invested capital to produce cash. It is calculated as Free Cash Flow [FCF] divided by invested capital [InvCapital].
- Total Debt - [Balance Sheet] The total debt is a component of [Liabilities] that represents principle balances held in exchange for interest paid (also know as loans). Includes secured and unsecured bonds issued, commercial paper, notes payable credit facilities, lines of credit, capital lease obligations, operating lease obligations, and convertible notes.
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
Definition of Invested Capital
[Calculation] Invested Capital is the total amount of money raised by a business in the form [Equity] and/or [Debt].Debt + Equity
(=) Inv. Capital Inv. Capital for BIOXCEL THERAPEUTICS INC is calculated as follows: Debt [ $ 1.47M ] + Equity [ $ 220.94M ]
(=) Inv. Capital [ $ 222.41M ] BTAI - Invested Capital, Last 5 years
$ 1.02M
Minimum
Jun 30, 2025
$ 268.67M
Maximum
Jun 30, 2021
$ 131.36M
Average
$ 159.69M
Median
Inv. Capital Benchmark AnalysisMarket
The chart above depicts the distribution of Inv. Capital for companies in the Total Stock Market. The average Inv. Capital of the companies is $ 762.5M with a standard deviation of $ 1B.
The following table provides additional summary stats:
Inv. Capital in the Market:
| filtered constituents | 3.44K |
|---|---|
| min | $ -1.51B |
| max | $ 4.14B |
| average | $ 762.5M |
| median | $ 304.41M |
| std | $ 1B |